Zobrazeno 1 - 10
of 22
pro vyhledávání: '"TJ Unger"'
Autor:
David Kubasiak, Tiffany Gareski, TJ Unger, Su-Ping Yeh, Sarah Will, Xiangping Li, Ariful Qadri, Nelson Huang, Mylene Perreault, Ruth Gimeno, Christian Baber, Sheila Ranganath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d42d89d57b9b0656c9643c6bd07fca22
https://doi.org/10.1210/endo-meetings.2011.part2.p8.p1-490
https://doi.org/10.1210/endo-meetings.2011.part2.p8.p1-490
Autor:
Pearson ADJ; ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium. Electronic address: andy1pearson@btinternet.com., Federico S; St Jude Children's Research Hospital, Memphis, TN, USA., Gatz SA; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ortiz M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Scobie N; Zoe4Life, Sullens, Switzerland., Gounaris I; Merck Serono Ltd (an affiliate of Merck KGaA, Darmstadt, Germany), Feltham, UK., Weiner SL; Children's Cancer Cause, Washington, DC, USA., Weigel B; University of Minnesota, Minneapolis, MN, USA., Unger TJ; Repare Therapeutics, Cambridge, MA, USA., Stewart E; St Jude Children's Research Hospital, Memphis, TN, USA., Smith M; National Cancer Institute, Bethesda, MD, USA., Slotkin EK; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reaman G; US Food and Drug Administration, Silver Springs, MD, USA., Pappo A; St Jude Children's Research Hospital, Memphis, TN, USA., Nysom K; Righospitalet, Copenhagen, Denmark., Norga K; Antwerp University Hospital, Antwerp, Belgium; Paediatric Committee of the European Medicines Agency (EMA), Amsterdam, the Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium., McDonough J; The Andrew McDonough B+ Foundation, Wilmington, DE, USA., Marshall LV; The Royal Marsden NHS Foundation Hospital, The Institute of Cancer Research, Sutton, Surrey, UK., Ludwinski D; Solving Kids' Cancer, New York, NY, USA., Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Kool M; Hopp Children's Cancer Center, Heidelberg, Germany., Horner TJ; GSK, Collegeville, PA, USA., Henssen A; Charité Berlin, Berlin, Germany., Heenen D; KickCancer, Brussels, Belgium., Hawkins DS; Seattle Children's Hospital, Seattle, WA, USA; Children's Oncology Group, Seattle, WA, USA., Gore L; Children's Hospital Colorado, Aurora, CO, USA; University of Colorado School of Medicine, Aurora, CO, USA., Bender JG; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Galluzzo S; Italian Medicine Agency (AIFA), Rome, Italy., Fox E; St Jude Children's Research Hospital, Memphis, TN, USA., de Rojas T; ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium., Davies BR; AstraZeneca, Cambridge, UK., Chakrabarti J; Pfizer, Tadworth, UK., Carmichael J; The Royal Marsden NHS Foundation Hospital, The Institute of Cancer Research, Sutton, Surrey, UK., Bradford D; US Food and Drug Administration, Silver Springs, MD, USA., Blanc P; Imagine for Margo, Paris, France., Bernardi R; Genentech, a Member of the Roche Group, South San Francisco, CA, USA., Benchetrit S; National Agency for the Safety of Medicine and Health Products, Paris, France., Akindele K; The Dorcas Foundation, Lagos, Nigeria., Vassal G; ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium; Gustave Roussy Cancer Centre, Paris, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Sep; Vol. 190, pp. 112950. Date of Electronic Publication: 2023 Jun 21.
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma.
Autor:
Cornell RF; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Baz R; Moffitt Cancer Center, Tampa, Florida, USA., Richter JR; Hackensack University John Theurer Cancer Center, Hackensack, New Jersey, USA., Rossi A; Weill Cornell Medical College Myeloma Center, New York, New York, USA., Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chen C; UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Shustik C; McGill University Health Centre, Montreal, Quebec, Canada., Alvarez MJ; DarwinHealth Inc., New York, New York, USA., Shen Y; DarwinHealth Inc., New York, New York, USA., Unger TJ; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Ben-Shahar O; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Wang H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Baloglu E; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Senapedis W; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Ma X; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Landesman Y; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Bai X; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Bader J; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Xu H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Marshall T; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Chang H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Walker CJ; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Shah J; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Shacham S; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Kauffman MG; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Hofmeister CC; Ohio State University, Columbus, Ohio, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2022 Feb 01; Vol. 97 (2), pp. E54-E58. Date of Electronic Publication: 2021 Nov 30.
Autor:
Sweet K; Moffitt Cancer Center, Tampa, FL, USA., Bhatnagar B; Ohio State University, Columbus, OH, USA., Döhner H; University of Ulm, Ulm, Germany., Donnellan W; Sarah Cannon Cancer Center, Nashville, TN, USA., Frankfurt O; Northwestern University, Chicago, IL, USA., Heuser M; Hannover Medical School, Hannover, Germany., Kota V; Emory University, Atlanta, GA, USA., Liu H; University of Chicago, Chicago, IL, USA., Raffoux E; Hôpital Saint-Louis, Paris, France., Roboz GJ; Weill Cornell Medicine, New York, NY, USA., Röllig C; Dresden University of Technology, Dresden, Germany., Showel MM; Johns Hopkins University, Baltimore, MD, USA., Strickland SA Jr; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Vives S; ICO Badalona-Hospital Germans Trias i Pujol, Badalona, Spain., Tang S; Karyopharm Therapeutics, Newton, MA, USA., Unger TJ; Karyopharm Therapeutics, Newton, MA, USA., Joshi A; Karyopharm Therapeutics, Newton, MA, USA., Shen Y; DarwinHealth Inc, New York, NY, USA., Alvarez MJ; DarwinHealth Inc, New York, NY, USA.; Columbia University, New York, NY, USA., Califano A; Columbia University, New York, NY, USA., Crochiere M; Karyopharm Therapeutics, Newton, MA, USA., Landesman Y; Karyopharm Therapeutics, Newton, MA, USA., Kauffman M; Karyopharm Therapeutics, Newton, MA, USA., Shah J; Karyopharm Therapeutics, Newton, MA, USA., Shacham S; Karyopharm Therapeutics, Newton, MA, USA., Savona MR; Vanderbilt University, Nashville, TN, USA., Montesinos P; Departamento de Hematologia, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (13), pp. 3192-3203. Date of Electronic Publication: 2021 Jul 29.
Autor:
Qasim SL; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Sierra L; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Shuck R; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Kurenbekova L; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Patel TD; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Rajapakshe K; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA., Wulff J; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Nakahata K; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Kim HR; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Landesman Y; Karyopharm Therapeutics Inc., Newton, MA, 02459, USA., Unger TJ; Karyopharm Therapeutics Inc., Newton, MA, 02459, USA., Coarfa C; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA., Yustein JT; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Cancer and Cell Biology Program, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.
Publikováno v:
Oncogene [Oncogene] 2021 Feb; Vol. 40 (6), pp. 1176-1190. Date of Electronic Publication: 2021 Jan 07.
Autor:
Gavriatopoulou M; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. mariagabria@gmail.com., Chari A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chen C; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Bahlis N; Charbonneau Cancer Research Institute, Calgary, AB, Canada., Vogl DT; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA., Dingli D; Mayo Clinic, Rochester, MN, USA., Cornell RF; Vanderbilt University Medical Center, Nashville, TN, USA., Hofmeister CC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Siegel D; Department of Hematology, John Theurer Cancer Center, Hackensack, NJ, USA., Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA., Reece D; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., White D; QEII Health Sciences Center, Dalhousie University, Halifax, NS, Canada., Lentzsch S; Department of Medicine, Division of Hematology/Oncology, Columbia University, New York, NY, USA., Gasparetto C; Duke University Cancer Center, Durham, NC, USA., Huff CA; Johns Hopkins University, Baltimore, MD, USA., Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Baz R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Richter J; Department of Hematology, John Theurer Cancer Center, Hackensack, NJ, USA., Abonour R; Indiana University Cancer Center, Indianapolis, IN, USA., Parker TL; Yale School of Medicine, New Haven, CT, USA., Yee AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Moreau P; University of Nantes, Nantes, France., Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Tuchman S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Weisel KC; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany., Mohty M; Hôpital Saint Antoine, Paris, France., Choquet S; La Pitié-Salpêtrière Hospital, Paris, France., Unger TJ; Karyopharm Therapeutics, Newton, MA, USA., Li K; Karyopharm Therapeutics, Newton, MA, USA., Chai Y; Karyopharm Therapeutics, Newton, MA, USA., Li L; Karyopharm Therapeutics, Newton, MA, USA., Shah J; Karyopharm Therapeutics, Newton, MA, USA., Shacham S; Karyopharm Therapeutics, Newton, MA, USA., Kauffman MG; Karyopharm Therapeutics, Newton, MA, USA., Dimopoulos MA; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
Leukemia [Leukemia] 2020 Sep; Vol. 34 (9), pp. 2430-2440. Date of Electronic Publication: 2020 Feb 24.
Autor:
Chari A; Icahn School of Medicine at Mount Sanai, New York, NY, USA., Vogl DT; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jagannath S; Icahn School of Medicine at Mount Sanai, New York, NY, USA., Jasielec J; University of Chicago Medical Center, Chicago, IL, USA., Unger TJ; Karyopharm Therapeutics, Newton, MA, USA., DeCastro A; Karyopharm Therapeutics, Newton, MA, USA., Shah J; Karyopharm Therapeutics, Newton, MA, USA., Kauffman M; Karyopharm Therapeutics, Newton, MA, USA., Shacham S; Karyopharm Therapeutics, Newton, MA, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2020 May; Vol. 189 (4), pp. e126-e130. Date of Electronic Publication: 2020 Mar 02.
Autor:
Vergote IB; Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union. Electronic address: ignace.vergote@uzleuven.be., Lund B; Aalborg University Hospital, Aalborg, Denmark., Peen U; Herlev University Hospital, Herlev, Denmark., Umajuridze Z; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Mau-Sorensen M; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Kranich A; GSO Hamburg, Germany., Van Nieuwenhuysen E; Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union., Haslund C; Aalborg University Hospital, Aalborg, Denmark., Nottrup T; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Han SN; Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union., Concin N; Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union., Unger TJ; Karyopharm Therapeutics Newton, MA, USA., Chai Y; Karyopharm Therapeutics Newton, MA, USA., Au N; Karyopharm Therapeutics Newton, MA, USA., Rashal T; Karyopharm Therapeutics Newton, MA, USA., Joshi A; Karyopharm Therapeutics Newton, MA, USA., Crochiere M; Karyopharm Therapeutics Newton, MA, USA., Landesman Y; Karyopharm Therapeutics Newton, MA, USA., Shah J; Karyopharm Therapeutics Newton, MA, USA., Shacham S; Karyopharm Therapeutics Newton, MA, USA., Kauffman M; Karyopharm Therapeutics Newton, MA, USA., Mirza MR; Karyopharm Therapeutics Newton, MA, USA.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2020 Feb; Vol. 156 (2), pp. 308-314. Date of Electronic Publication: 2019 Dec 09.
Autor:
Bahlis NJ; Charbonneau Cancer Research Institute, Calgary, AB, Canada., Sutherland H; Vancouver General Hospital, Vancouver, BC, Canada., White D; QEII Health Sciences Center, Dalhousie University, Halifax, NS, Canada., Sebag M; Royal Victoria Hospital, Montreal, QC, Canada., Lentzsch S; Multiple Myeloma and Amyloidosis Service, Columbia University, New York, NY., Kotb R; Cancer Centre Manitoba, Winnipeg, MB, Canada., Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Gasparetto C; Duke University Cancer Center, Durham, NC., Del Col A; Myeloma Canada, Dorval, QC, Canada., Neri P; Charbonneau Cancer Research Institute, Calgary, AB, Canada., Reece D; Princess Margaret Cancer Center, Toronto, ON, Canada; and., Kauffman M; Karyopharm Therapeutics Inc, Newton, MA., Shacham S; Karyopharm Therapeutics Inc, Newton, MA., Unger TJ; Karyopharm Therapeutics Inc, Newton, MA., Jeha J; Karyopharm Therapeutics Inc, Newton, MA., Saint-Martin JR; Karyopharm Therapeutics Inc, Newton, MA., Shah J; Karyopharm Therapeutics Inc, Newton, MA., Chen C; Princess Margaret Cancer Center, Toronto, ON, Canada; and.
Publikováno v:
Blood [Blood] 2018 Dec 13; Vol. 132 (24), pp. 2546-2554. Date of Electronic Publication: 2018 Oct 23.
Autor:
Argueta C; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Kashyap T; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Klebanov B; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Unger TJ; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Guo C; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Harrington S; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Baloglu E; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Lee M; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Senapedis W; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Shacham S; Karyopharm Therapeutics Inc, Newton, MA 02459, USA., Landesman Y; Karyopharm Therapeutics Inc, Newton, MA 02459, USA.
Publikováno v:
Oncotarget [Oncotarget] 2018 May 22; Vol. 9 (39), pp. 25529-25544. Date of Electronic Publication: 2018 May 22 (Print Publication: 2018).